V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330001976 | 330001123 | 1.63 | 9.6 | Curative (C) | 2013-02-04 | 2013-02-09 | Trial Unspecified | Y | N | 330007602 | TRIAL |
| 330001977 | 330001124 | 1.73 | 73.1 | null | 2017-03-06 | 2017-03-12 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330007603 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001978 | 330001124 | null | null | Curative (C) | 2015-11-20 | 2015-12-15 | Cisplatin 7 day | 02 | Y | 330007603 | CISPLATIN |
| 330001979 | 330001125 | null | 8.7 | null | 2015-08-21 | 2015-08-21 | STS Rhabdomyosarcoma RMS 2005 IVAVV | 02 | N | 330007606 | NOT MATCHED |
| 330001980 | 330001125 | 1.75 | 67.8 | Curative (C) | 2013-10-14 | 2013-11-08 | Cisplatin | N | Y | 330007606 | CISPLATIN |
| 330001983 | 330001127 | 1.56 | 63 | Neo-adjuvant (N) | 2016-04-02 | 2016-04-07 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | null | 330007616 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001984 | 330001127 | 1.77 | null | Curative (C) | 2014-10-07 | 2014-10-12 | EW EuroEwing 2012 Arm B VDC | 01 | N | 330007616 | TRIAL |
| 330001985 | 330009562 | 1.64 | 49.2 | Curative (C) | null | 2017-01-02 | Cisplatin | N | N | 330007619 | CISPLATIN |
| 330001986 | 330009562 | 1.8 | 77.2 | Curative (C) | 2013-12-01 | 2013-12-11 | NB HRNBL-1 COJEC Ind COURSE B | Y | N | 330007619 | NOT MATCHED |
| 330001987 | 330001128 | 1.71 | null | Palliative (P) | 2015-02-22 | 2015-02-28 | Cisplatin + Docetaxel +Fluorouracil | null | null | 330007623 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001988 | 330001128 | 1.73 | 15.3 | Curative (C) | 2014-04-22 | 2014-05-21 | Cisplatin | N | Y | 330007623 | CISPLATIN |
| 330001989 | 330009563 | null | null | Curative (C) | 2016-02-22 | 2016-02-22 | NB HRNBL-1 COJEC Ind COURSE A | Y | Y | 330007628 | NOT MATCHED |
| 330001992 | 330001130 | 0 | 69.9 | Curative (C) | 2014-05-10 | 2014-05-11 | NB HRNBL-1 COJEC Ind COURSE A | 02 | N | 330007645 | NOT MATCHED |
| 330001993 | 330006609 | null | 86 | Curative (C) | 2013-09-01 | 2013-09-02 | LCHIV Cont A | Y | null | 330007647 | NOT MATCHED |
| 330001994 | 330006609 | 0 | 27.3 | null | 2015-05-11 | 2015-05-11 | CNS PNET III Vinc, Carbo, Etoposide | N | null | 330007647 | NOT MATCHED |
| 330001995 | 330001131 | 1.8 | 82 | null | 2017-10-28 | 2017-12-05 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | null | 330007650 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001996 | 330001132 | 1.71 | 12.1 | Curative (C) | 2013-01-12 | 2013-03-26 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330007652 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330001997 | 330001133 | 1.55 | 58 | Curative (C) | 2015-10-27 | 2015-11-24 | Cisplatin | null | N | 330007656 | CISPLATIN |
| 330001998 | 330001133 | null | 55.9 | Adjuvant (A) | 2015-05-27 | 2015-05-28 | Cisplatin | N | Y | 330007656 | CISPLATIN |
| 330001999 | 330001133 | 1.81 | 74 | Neo-adjuvant (N) | null | 2017-01-06 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | null | 330007656 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002000 | 330001134 | 1.71 | 64.1 | Curative (C) | 2017-11-03 | 2017-11-25 | Cisplatin | 02 | Y | 330007661 | CISPLATIN |
| 330002001 | 330001134 | 1.75 | 92 | Curative (C) | 2016-04-28 | 2016-05-10 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330007661 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002002 | 330001135 | 1.77 | 72 | null | 2014-03-27 | 2014-04-19 | Cisplatin 7 day | N | Y | 330007663 | CISPLATIN |
| 330002003 | 330001136 | null | 43.2 | Palliative (P) | 2015-06-15 | 2015-07-09 | Cisplatin 7 day | N | Y | 330007664 | CISPLATIN |
| 330002004 | 330001137 | 1.71 | 5.7 | Neo-adjuvant (N) | 2015-01-13 | 2015-01-18 | Cisplatin + Docetaxel +Fluorouracil | null | N | 330007665 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002005 | 330001138 | 0 | 14.5 | Palliative (P) | 2017-08-17 | 2017-08-31 | Trial Unspecified | N | null | 330007666 | TRIAL |
| 330002006 | 330001139 | 1.6 | 90.3 | Curative (C) | 2016-06-11 | 2016-07-06 | Cisplatin | N | N | 330007670 | CISPLATIN |
| 330002007 | 330001139 | 1.59 | 58.2 | Neo-adjuvant (N) | 2014-05-16 | 2014-05-22 | Cisplatin + Docetaxel +Fluorouracil | N | null | 330007670 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002008 | 330001140 | 1.73 | 109.2 | Curative (C) | 2015-02-11 | 2015-02-21 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 330007673 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002009 | 330001140 | 1.6 | 91 | Neo-adjuvant (N) | 2015-06-09 | 2015-06-18 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330007673 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002010 | 330001141 | null | null | Curative (C) | 2015-05-17 | 2015-05-28 | NB Low/Interm risk guidelines | N | N | 330007677 | NOT MATCHED |
| 330002011 | 330001141 | 1.72 | 58.9 | Palliative (P) | null | 2018-05-07 | Cisplatin + Docetaxel +Fluorouracil | null | N | 330007677 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002012 | 330001142 | null | 71 | Curative (C) | 2017-08-02 | 2017-08-13 | Bortezomib + RITUXIMAB + THALIDOMIDE | 02 | null | 330007683 | NOT MATCHED |
| 330002013 | 330001142 | 1.64 | 14.6 | Curative (C) | null | 2015-05-04 | Cisplatin | N | Y | 330007683 | CISPLATIN |
| 330002014 | 330001143 | 1.8 | 100.9 | null | 2016-08-17 | 2016-09-03 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 330007685 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002015 | 330006616 | 1.52 | 63.2 | Not known (9) | 2017-01-19 | 2017-01-19 | EW EuroEwing 2012 Arm B VDC | Y | N | 330007689 | TRIAL |
| 330002016 | 330006616 | null | 59 | Curative (C) | 2015-11-23 | 2015-11-30 | CYTARABINE + DAUNORUBICIN + VINCRISTINE | N | N | 330007689 | NOT MATCHED |
| 330002017 | 330001144 | 1.83 | 72 | Palliative (P) | 2014-10-02 | 2014-10-04 | Trial Unspecified | null | N | 330007695 | TRIAL |
| 330002018 | 330001144 | 0 | 74.4 | Curative (C) | 2017-08-21 | 2017-08-24 | EW EuroEwing 2012 Arm A VAC | 1 | N | 330007695 | NOT MATCHED |
| 330002019 | 330001144 | 1.66 | 22.8 | Neo-adjuvant (N) | null | 2015-01-01 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | Y | 330007695 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002020 | 330001144 | 1.62 | 45.1 | Neo-adjuvant (N) | 2013-06-28 | 2013-07-20 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 330007695 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002021 | 330001144 | 1.72 | 0 | Neo-adjuvant (N) | 2014-04-07 | 2014-04-30 | Cisplatin + Docetaxel +Fluorouracil | N | null | 330007695 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002022 | 330001145 | 1.8 | 83 | Neo-adjuvant (N) | 2013-12-19 | 2013-12-25 | Cisplatin + Docetaxel +Fluorouracil | 2 | null | 330007714 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002023 | 330001146 | 1.6 | 84 | Neo-adjuvant (N) | 2015-12-01 | 2015-12-08 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 330007716 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002024 | 330001147 | 1.78 | 59.5 | Curative (C) | 2013-03-04 | 2013-03-04 | Trial Unspecified | Y | N | 330007719 | TRIAL |
| 330002025 | 330001147 | 1.57 | 72.1 | Neo-adjuvant (N) | null | 2016-03-07 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330007719 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002026 | 330001148 | 1.77 | 58.3 | Neo-adjuvant (N) | 2016-12-08 | 2016-12-17 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330007725 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002027 | 330001149 | 1.8 | 81.8 | Neo-adjuvant (N) | null | 2016-11-16 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 330007728 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002028 | 330001149 | null | 69 | null | 2015-04-17 | 2015-04-18 | NB HRNBL-1 BUMEL MAT | N | N | 330007728 | NOT MATCHED |
| 330002029 | 330001150 | 1.67 | 64.1 | Curative (C) | 2017-05-19 | 2017-05-26 | Cisplatin | 2 | Y | 330007731 | CISPLATIN |